Prevest Denpro Share Price
Small Cap | Pharmaceuticals and health care | BSE: 543363
₹401.00 
-3.45 (-0.85 %)
Last Updated: 13 Mar 2025 12:00 AM
BEARISH
Overview
Open (₹) 404.00
High (₹) 415.00
Low (₹) 400.00
Prev. Close (₹) 404.45
Volume 1,38,000
VWAP (₹) 421.93
ROCE (%) 23.99
Industry P/E 66.82
TTM P/E 27.06
P/B Ratio 5.43
Market Cap (₹) Cr.481.32
Dividend Yield (%)0.25
EPS (₹) 13.45
ROE18.22%
Sales Growth (%) --
Profit Growth (%)--
Day Range
415.00415.00
52 Week Range
332.00686.00
Historical Returns
Returns (6M)
-31.57 %
Returns (1Y)
7.58 %
Returns (3Y)
7.8 %
Returns (5Y)
111.55 %
Returns (6M)
-31.57 %
Returns (1Y)
7.58 %
Returns (3Y)
7.8 %
Returns (5Y)
111.55 %
SWOT Analysis
Technicals
Technical Rating
BEARISHRSI 36.49
MFI 43.87
ATR 39.86
Commodity Channel Index -94.32
ROC125 -25.62
ROC21 -23.05
Williams %R -84.13
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 434.80 | 444.90 | 454.80 | 424.90 | 414.80 | 404.90 | 394.80 |
| Week Ago | 465.69 | 478.97 | 486.84 | 457.82 | 444.54 | 436.67 | 423.39 |
| Month Ago | 548.30 | 568.25 | 586.40 | 530.15 | 510.20 | 492.05 | 472.10 |
EMA & SMA
401.00
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 441.93
9 Day 439.33
10 Day 447.88
12 Day 456.94
14 Day 469.94
20 Day 488.63
26 Day 504.85
50 Day 549.51
100 Day 555.49
200 Day 548.64
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| RAMLAL KANWARLAL JAIN | bulk | Sell | 09 Feb, 2022 | ₹345.16 | 64,000 | BSE |
| VINOD H BIYANI | bulk | Sell | 31 Jan, 2022 | ₹401.26 | 12,800 | BSE |
| NEXT ORBIT VENTURES FUND | bulk | Sell | 31 Jan, 2022 | ₹391.17 | 1,47,200 | BSE |
| VINOD H BIYANI | bulk | Buy | 31 Jan, 2022 | ₹390.50 | 1,28,000 | BSE |
| RAMLAL KANWARLAL JAIN | bulk | Buy | 03 Jan, 2022 | ₹454.91 | 72,000 | BSE |
| NEXT ORBIT VENTURES FUND | bulk | Sell | 31 Dec, 2021 | ₹433.75 | 78,400 | BSE |
| NEXT ORBIT VENTURES FUND | bulk | Buy | 31 Dec, 2021 | ₹433.75 | 3,200 | BSE |
| SHAH SHARAD KANAYALAL | bulk | Buy | 09 Dec, 2021 | ₹363.30 | 70,400 | BSE |
| MARUTI NANDAN COLONIZERS PRIVATE LIMITED | bulk | Sell | 11 Oct, 2021 | ₹279.47 | 1,34,400 | BSE |
| EQUITYINTELLIGENCEINDIA PRIVATELIMITED | bulk | Buy | 07 Oct, 2021 | ₹228.91 | 92,800 | BSE |
Insider Trading
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 08 Aug, 2024 | Rs.1.0000 per share(10%)Final Dividend | 30 Aug, 2024 | 30 Aug, 2024 |
| 03 Aug, 2023 | Rs.1.0000 per share(10%)Final Dividend | 23 Aug, 2023 | 23 Aug, 2023 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 12 Feb, 2025 | BSE India | Integrated filing (financial) for the quarter and nine months ended December 31, 2024. |
| 10 Feb, 2025 | BSE India | Investor Presentation on the Financial Results for the quarter ended on December 31, 2024. |
| 01 Feb, 2025 | BSE India | Intimation of Investment in Axiodent Inc. |
| 01 Feb, 2025 | BSE India | Statement of deviation or variation of funds for the quarter ended on December 31, 2024. |
| 01 Feb, 2025 | BSE India | Considered and approved the unaudited financial results (standalone and consolidated) of the Company for quarter ended on December 31, 2024. |
| 01 Feb, 2025 | BSE India | Considered and approved the unaudited financial results (standalone and consolidated) of the Company for the quarter ended on December 31, 2024. |
| 27 Jan, 2025 | BSE India | Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2025 ,inter alia, to consider and approve the un-audited Financial Results of the Company for the quarter ended on December 31, 2024. |
| 22 Nov, 2024 | BSE India | Transcript of conference call with Investors and Analysts held on November 20, 2024 |
| 21 Nov, 2024 | BSE India | Pursuant to Regulation 30 and 46 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015 read along with SEBI (Listing Obligation & Disclosure Requirements) (Second Amendment) Regulations, 2021, please find audio recording of the Company's Earning Call held with the Investors/ Analysis on November 20, 2024 to discuss Financial Results of the Company for the quarter ended September 30, 2024. |
| 19 Nov, 2024 | BSE India | Investor Presentation on the Financial Results for the quarter ended on September 30, 2024 |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 28 Jan, 2025 | 01 Feb, 2025 |
| Half Yearly Results | -- | 05 Nov, 2024 | 11 Nov, 2024 |
| Quarterly Results & Final Dividend | -- | 01 Aug, 2024 | 08 Aug, 2024 |
| Audited Results | (Revised) | 07 May, 2024 | 28 May, 2024 |
| Audited Results | -- | 07 May, 2024 | 10 May, 2024 |
| Quarterly Results | -- | 25 Jan, 2024 | 03 Feb, 2024 |
| Half Yearly Results | -- | 27 Oct, 2023 | 03 Nov, 2023 |
| Quarterly Results, Final Dividend & A.G.M. | -- | 28 Jul, 2023 | 03 Aug, 2023 |
| Audited Results | -- | 20 Apr, 2023 | 27 Apr, 2023 |
| Quarterly Results | -- | 08 Feb, 2023 | 13 Feb, 2023 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About Prevest Denpro
Prevest Denpro is a Public Limited Listed company incorporated on 05/05/1999 and has its registered office in the State of Jammu & Kashmir, India. Company’s Corporate Identification Number(CIN) is L85199JK1999PLC001969 and registration number is 001969. Currently company belongs to the Industry of Medical Equipment & Accessories. Company’s Total Operating Revenue is Rs. 56.44 Cr. and Equity Capital is Rs. 12.00 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1999
Managing Director
Mr. Atul Modi
NSE Symbol
--
Prevest Denpro Management
| Name | Designation |
|---|---|
| Mr. Atul Modi | Chairman & Managing Director |
| Mrs. Namrata Modi | WholeTime Director & CFO |
| Dr. Sai Kalyan Surapaneni | Executive Director |
| Mr. Vaibhav Munjal | Executive Director |
| Ms. Niharika Modi | Non Executive Director |
| Dr. Nikhil Shrikant Bobade | Independent Director |
| Dr. Sudeep Murthy | Independent Director |
| Mr. Pardeep Gandotra | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Poly Medicure | ₹22,436.05 | ₹2,214.25  ₹2,219.90(-0.25%) | ₹1,373.000 - ₹3,350.000 |
| Tarsons Products | ₹1,570.38 | ₹295.15 ₹305.55(-3.40%) | ₹283.050 - ₹543.800 |
| Borosil Scientific | ₹1,063.81 | ₹119.64 ₹124.77(-4.11%) | ₹118.000 - ₹229.800 |
| Vasa Denticity | ₹998.05 | ₹600.45 ₹610.50(-1.65%) | ₹401.000 - ₹840.000 |
| Prevest Denpro | ₹481.32 | ₹401.00 ₹404.45(-0.85%) | ₹332.000 - ₹686.000 |
FAQs on Prevest Denpro
What is the share price of Prevest Denpro?
The share price of Prevest Denpro on 13 Mar, 2025 is ₹ 401.00.
What is 52W high and 52W low share price of Prevest Denpro?
The highest and lowest 52W share prices of Prevest Denpro are ₹ 686.000 and ₹ 332.000
What is the market cap of Prevest Denpro?
The market capitalization of Prevest Denpro as of 13 Mar, 2025 is ₹ 481.32 Crores
What is the P/E ratio of Prevest Denpro?
The current P/E ratio of Prevest Denpro as of 13 Mar, 2025 is 66.82
What is the PB ratio of Prevest Denpro?
The PB ratio of Prevest Denpro as of 13 Mar, 2025 is 5.43
Top Gainers
₹41.02
₹34.29 (0.20%)
₹8.84
₹7.37 (0.20%)
₹6.97
₹5.81 (0.20%)
₹194.70
₹162.25 (0.20%)
Top Losers
₹13.75
₹135.15 (-0.90%)
₹9.60
₹12.00 (-0.20%)
₹9.80
₹93.55 (-0.90%)
₹0.99
₹4.77 (-0.79%)
Market Indices
Sensex
₹73,828.91
₹74,029.76 (0.00%)